Cdc6 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc6 monoclonal antibodies for research in cell cycle regulation and DNA replication. Cdc6 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc6, a crucial component in the initiation of DNA replication, plays a significant role in the regulation of the cell cycle. The loading of the MCM2-7 helicase complex onto DNA requires Cdc6, which facilitates the unwinding of DNA strands for replication. Dysregulation of Cdc6 has been implicated in various cancers, making it an important target for therapeutic research. Understanding Cdc6's role in cell cycle progression provides valuable insights into cancer development and potential treatment strategies. Research utilizing Cdc6 monoclonal antibodies continues to reveal new aspects of cell cycle control mechanisms. Investigating Cdc6 function helps illuminate the complexities of DNA replication and cellular division. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cell cycle regulation and cancer biology.